👤 Riping Wu

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
1732
Articles
1210
Name variants
Also published as: Jiake Wu, Ming-Jiuan Wu, Siying Wu, Yijian Wu, Fong-Li Wu, Chih-Chung Wu, Jin'en Wu, Zixiang Wu, D P Wu, Zhongwei Wu, Haiping Wu, Geyan Wu, Qi-Zhu Wu, Jianjin Wu, Su Wu, Shwu-Yuan Wu, Xiaodi Wu, Changxin Wu, Kuen-Phon Wu, Guofeng Wu, Zhiping Wu, Xiaojun Wu, Qibing Wu, Junhua Wu, Cheng-Hsin Wu, Xiaoting Wu, Wenze Wu, Yandi Wu, Hong Wu, Zhong Wu, An-Chih Wu, Jianhui Wu, Xiaoke Wu, Zhenguo Wu, Jason H Y Wu, Yi-Mi Wu, Bing-Bing Wu, Selena Meiyun Wu, M Wu, Hui-Mei Wu, Danni Wu, Minqing Wu, Sijie Wu, Geng-ze Wu, Kun Wu, Cheng-Hua Wu, Shaofei Wu, Zhaoyang Wu, Qihan Wu, Kunling Wu, R Ryanne Wu, Hao Wu, Mingxuan Wu, Pei Wu, Wendy Wu, Yukang Wu, Jingtao Wu, Douglas C Wu, Guizhen Wu, Zhangjie Wu, Lili Wu, Jianwu Wu, Min-Jiao Wu, Biaoliang Wu, Huan Wu, Shengxi Wu, Fei-Fei Wu, Peih-Shan Wu, Guoqing Wu, Yu-Yuan Wu, Pei-Yu Wu, Geting Wu, Lun-Gang Wu, Jing Wu, Dongzhe Wu, G Wu, Junlong Wu, Jia-Jun Wu, Jiangyue Wu, Muzhou Wu, Ray-Chin Wu, Jian-Qiu Wu, Junzhu Wu, T Wu, Jianxiong Wu, Liping Wu, Haiwei Wu, Guoping Wu, Yong-Hao Wu, Jin-hua Wu, Yi Wu, Chongming Wu, You Wu, Qunzheng Wu, Xudong Wu, Liqiang Wu, Cuiling Wu, Kunfang Wu, Limeng Wu, Bian Wu, Jason Wu, Zhibing Wu, Shuying Wu, Caihong Wu, Naqiong Wu, Huating Wu, Joseph C Wu, Tianhao Wu, Zhi-Hong Wu, Congying Wu, Gaojun Wu, Dongping Wu, Chiao-En Wu, Li Wu, Yihang Wu, Haixia Wu, Shaoxuan Wu, Fanchang Wu, Gen Wu, Xiaorong Wu, Mingjie Wu, Mei Wu, Jiahao Wu, Jiapei Wu, Jia Wu, Lingqian Wu, Fangge Wu, Sen-Chao Wu, Yanhui Wu, Zhiqiang Wu, Shugeng Wu, Sarah Wu, Dongmei Wu, Xuanqin Wu, Caiwen Wu, Junjing Wu, Jiangdong Wu, Guihua Wu, Meini Wu, Yingbiao Wu, Rui Wu, Hua-Yu Wu, Bifeng Wu, Jingwan Wu, Lingling Wu, Junzheng Wu, Xinmiao Wu, Yi-Fang Wu, Yuyi Wu, Yixuan Wu, Leilei Wu, Qinglin Wu, Bin Wu, Tianqi Wu, Shiya Wu, Hui-Chen Wu, Jian Wu, Cong Wu, Sijun Wu, Yiwen Wu, Feng Wu, Xi-Ze Wu, Qiuji Wu, Alexander T H Wu, Qinan Wu, Semon Wu, Lai Man Natalie Wu, Zhuokai Wu, Ran Wu, Panyun Wu, Kui Wu, Yumei Wu, Biwei Wu, Xinrui Wu, Yueling Wu, Xing Wu, Jiayi Wu, Hua Wu, Yuen-Jung Wu, Bingjie Wu, Xiaoliang Wu, Matthew A Wu, Jin Wu, Juanjuan Wu, Qiuhong Wu, Hongfu Wu, Xiaoming Wu, Ming-Sian Wu, Ronghua Wu, Junduo Wu, Dandan Wu, Yuliang Wu, Ming-Shiang Wu, Ying-Ying Wu, Chaoling Wu, Guang-Liang Wu, De Wu, Yihua Wu, Yuanyuan Wu, Tsung-Jui Wu, Yulian Wu, Han Wu, Lipeng Wu, Zhihao Wu, Jiexi Wu, Anna H Wu, Qiu Wu, Huazhen Wu, Yaqin Wu, Shengru Wu, Chieh-Lin Stanley Wu, Xiaoqian Wu, Xiahui Wu, Jianli Wu, Yun-Wen Wu, Jian-Yi Wu, Qiuya Wu, Tsai-Kun Wu, Xinyin Wu, Guoyao Wu, Zhenfeng Wu, Guoli Wu, J W Wu, Bill X Wu, Zujun Wu, Jianliang Wu, Yuanshun Wu, Ling-Ying Wu, Zeng-An Wu, Xue Wu, Jianrong Wu, Ke Wu, Mengxue Wu, Cheng-Yang Wu, Jinghong Wu, Rongrong Wu, Ruolan Wu, Rong Wu, Kevin Zl Wu, Xiaohong Wu, Run Wu, Zaihao Wu, Chaowei Wu, Yu-Ke Wu, Xinjing Wu, Anyue Wu, Shu Wu, Yun Wu, Xuan Wu, Meili Wu, Wanxia Wu, Yi-No Wu, Chao-Liang Wu, Chengwei Wu, Y-W Wu, Pensee Wu, Zhao-Bo Wu, Guangxian Wu, Xiao Wu, Juanli Wu, Xinlei Wu, Changjie Wu, Sai Wu, Jiawei Wu, Yujuan Wu, Haoze Wu, Renlv Wu, Xiaoyang Wu, Yipeng Wu, Yuh-Lin Wu, Yu'e Wu, An-Hua Wu, Dan-Chun Wu, Meng-Chao Wu, Yuanhao Wu, Jer-Yuarn Wu, Qian-Yan Wu, Guangyan Wu, Huisheng Wu, Huijuan Wu, Shuting Wu, Long-Jun Wu, Alice Ying-Jung Wu, Xiru Wu, Zhenfang Wu, Lidi Wu, Yetong Wu, Disheng Wu, Linmei Wu, Huiwen Wu, Zhenzhou Wu, Yuhong Wu, Liang Wu, Liyan Wu, Kuan-Li Wu, Pei-Ting Wu, Xiao-Jin Wu, Lifeng Wu, Terence Wu, Shujuan Wu, Gang Wu, Xue-Mei Wu, Szu-Hsien Wu, Yan-ling Wu, Xiaokang Wu, Lingyan Wu, Yih-Jer Wu, Xinghua Wu, Chunfu Wu, Yingxia Wu, Rongling Wu, Xifeng Wu, Jinhua Wu, Sihan Wu, Ming-Yue Wu, Shiyang Wu, K D Wu, Luyan Wu, Jinmei Wu, Shin-Long Wu, Shuai Wu, Zhipeng Wu, Guangzhen Wu, Zhixiang Wu, Longting Wu, Zhengsheng Wu, Xiaoqiong Wu, Yaoxing Wu, Yuqin Wu, Yudan Wu, Zoe Wu, Hongting Wu, Chi-Jen Wu, R Wu, Zhongqiu Wu, Meina Wu, Dengying Wu, Anke Wu, Cheng-Jang Wu, Hsi-Chin Wu, Shufang Wu, Yongjiang Wu, Yuan-de Wu, Sihui Wu, Qi Wu, Wenhui Wu, Fenfang Wu, K S Wu, Nana Wu, Jianzhi Wu, Lin-Han Wu, Zhen Wu, Jinjun Wu, Chen-Lu Wu, Jing-Fang Wu, Haiyan Wu, Yihui Wu, Qiqing Wu, Zhengzhi Wu, Dai-Chao Wu, Zhenyan Wu, Wen-Jeng Wu, Yongqun Wu, Sean M Wu, Guanming Wu, Hei-Man Wu, Su-Hui Wu, Diana H Wu, Ben J Wu, Pingxian Wu, Chew-Wun Wu, Yillin Wu, Jiang-Bo Wu, Xiaobing Wu, Jerry Wu, Siming Wu, Zijun Wu, Daqing Wu, Yu-Hsuan Wu, Lichao Wu, Zhimin Wu, Qijing Wu, Daxian Wu, Zhaoyi Wu, Z Wu, Tong Wu, Cheng-Chun Wu, Tracy Wu, Shusheng Wu, D Wu, Ting-Ting Wu, Xiao-Yan Wu, Lan Wu, J Wu, Changchen Wu, Qi-Fang Wu, Changwei Wu, Liangyan Wu, Liufeng Wu, Kan Wu, Eugenia Wu, Mingming Wu, Xiaolong Wu, Chunru Wu, Zhaofei Wu, Shenhao Wu, Li-Peng Wu, Yuna Wu, Minna Wu, Justin Che-Yuen Wu, Buling Wu, Chengyu Wu, Wutian Wu, Yuwei Wu, Guixin Wu, Hei Man Wu, Haijing Wu, Qiuchen Wu, Junfei Wu, Xiao-Hui Wu, Xiaofeng Wu, Linyu Wu, Wenda Wu, Yung-Fu Wu, Mengbo Wu, Zhenling Wu, Maoqing Wu, Zuping Wu, Chun-Chieh Wu, Julian Wu, Binbin Wu, Xiaohui Wu, Qian Wu, Xinchun Wu, Shuisheng Wu, Linxiang Wu, Xueqing Wu, Bo Wu, Moxin Wu, Xiao-Cheng Wu, Anzhou Wu, Shuyi Wu, Jiahui Wu, Meiqin Wu, Jer-Yuan Wu, Shihao Wu, Wen-Shu Wu, Wudelehu Wu, Ruonan Wu, Song Wu, Yulin Wu, De-Fu Wu, Hongyu Wu, Yurong Wu, Zixuan Wu, Shih-Ying Wu, Chih-Hsing Wu, Chengrong Wu, Yinghao Wu, Yuanzhao Wu, Wenjie Wu, Baochuan Wu, Ziliang Wu, Liuting Wu, Chia-Ling Wu, Y Q Wu, Man Wu, Na Wu, Wutain Wu, Chenyang Wu, Selwin K Wu, Jinyu Wu, Ping Wu, Lorna Wu, D I Wu, Yi-Cheng Wu, Jianzhong Wu, Xiaoyun Wu, Zhourui Wu, Li-Jun Wu, Xinhe Wu, Zhi-Wei Wu, Yinan Wu, Xinyan Wu, Xin Wu, Yawei Wu, Ting-Feng Wu, Shixin Wu, Xiaojin Wu, Tsung-Teh Wu, Jiarui Wu, Hong-Mei Wu, Yiqun Wu, Qi-Nian Wu, Ju Wu, Kai-Yue Wu, Pengjie Wu, Xi-Chen Wu, Zhe Wu, Shaoping Wu, Zhou Wu, Han-Jie Wu, Haijiang Wu, Weijie Wu, Hongfei Wu, Xiaojie Wu, Yi-Ying Wu, Zhentian Wu, Ze Wu, Kai-Hong Wu, Yuting Wu, Minyao Wu, Xueyan Wu, Shinan Wu, Feifei Wu, Yonghui Wu, Haoxuan Wu, Yanzhi Wu, Yiyi Wu, Dong Wu, Guohao Wu, Wenjing Wu, Shibo Wu, Wenqian Wu, Tian Wu, Tiantian Wu, Hai-Yan Wu, Chong Wu, Hongxian Wu, Daoyuan Wu, Zongfu Wu, Ling Wu, Yuxiang Wu, Xilong Wu, Yuyu Wu, Zong-Jia Wu, Huijian Wu, Fengming Wu, Guorong Wu, Chuanhong Wu, Choufei Wu, Chi-Chung Wu, Junfang Wu, Xingwei Wu, Ling-Fei Wu, Xiaoqing Wu, Xinyang Wu, Xiaomin Wu, Yili Wu, Hong-Fu Wu, Shao-Ming Wu, Thomas D Wu, Lizhen Wu, Yuanming Wu, Hsien-Ming Wu, Jian Hui Wu, Litong Wu, Yuxian Wu, Weihua Wu, Lei Wu, C Wu, Wei Wu, Yu-E Wu, Qiulian Wu, Yuexiu Wu, Mei-Hwan Wu, Shaoze Wu, Zilong Wu, Chi-Hao Wu, Baojin Wu, Chao Wu, Yao Wu, Ya Wu, Do-Bo Wu, Wenjun Wu, Zhongren Wu, Nini Wu, Michael C Wu, Ning Wu, Jie Wu, Ming J Wu, Yi-Syuan Wu, Zhenzhen Wu, Limei Wu, Wen-Chieh Wu, Tianwen Wu, Junfeng Wu, Yunhua Wu, Shunan Wu, Junqi Wu, Jianing Wu, Honglin Wu, Maureen Wu, Yexiang Wu, Yan-Hua Wu, Mengjun Wu, Y H Wu, Liuying Wu, Mingxing Wu, Suhua Wu, Xiaomeng Wu, Shyh-Jong Wu, Tung-Ho Wu, Hongliang Wu, Wenxian Wu, Xuekun Wu, Ed Xuekui Wu, Wenqiang Wu, Chuang Wu, Jingyi Wu, Duojiao Wu, Xueyuan Wu, Ji-Zhou Wu, Lianqian Wu, Gaige Wu, Qing-Qian Wu, Haihu Wu, Xiushan Wu, Xueyao Wu, Tingchun Wu, Yafei Wu, Lingxi Wu, R-J Wu, Weidong Wu, Re-Wen Wu, Zhidan Wu, Peiyao Wu, Xuemei Wu, Yiting Wu, Chen Wu, Kerui Wu, Lihong Wu, Shiqi Wu, Liren Wu, Xiuhua Wu, Beili Wu, Yongqi Wu, Ruihong Wu, Huini Wu, Guang-Long Wu, Lingyun Wu, Po-Chang Wu, Wenxue Wu, Qinghua Wu, Ru-Zi Wu, Changjing Wu, Wenlin Wu, Xiexing Wu, J Y Wu, Jianping Wu, Guanggeng Wu, W J Wu, Zhichong Wu, Di Wu, Shaoyu Wu, Xiaotong Wu, Junyong Wu, Hui Wu, Shengde Wu, Hongyan Wu, Mengyuan Wu, Yutong Wu, Zheming Wu, Yiping Wu, Guiping Wu, Wen-Hui Wu, Dapeng Wu, Bing Wu, Wen-Sheng Wu, Yunpeng Wu, Li-Ling Wu, Xiao-Yuan Wu, Qiu-Li Wu, Baiyan Wu, Xiao-Ye Wu, Ying Wu, Da-Hua Wu, Hsing-Chieh Wu, Hui-Xuan Wu, Chieh-Jen Wu, Pengning Wu, Sichen Wu, S F Wu, Mengying Wu, Ming-Der Wu, Jia-En Wu, Weida Wu, Qi-Jun Wu, Guo-Chao Wu, Qi-Biao Wu, Zhenyong Wu, Yangfeng Wu, Lijie Wu, Zhiye Wu, Jihui Wu, JieQian Wu, Zhengliang L Wu, Qianqian Wu, Jingyun Wu, Xiaoman Wu, Ruohao Wu, Yiyang Wu, Zhengfeng Wu, Xiao-Jun Wu, Lizi Wu, Qiang Wu, J-Z Wu, Guangjie Wu, Pengfei Wu, Jundong Wu, Beier Wu, Jianying Wu, Meng-Ling Wu, Lingxiang Wu, Jamie L Y Wu, Keija Wu, Xilin Wu, Yanhua Wu, An-Li Wu, Yi-Ming Wu, Chengbiao Wu, Huanghui Wu, Dong-Feng Wu, Kunsheng Wu, Zhengcan Wu, Yuxin Wu, Kun-Rong Wu, Dong-Fang Wu, Guanxian Wu, Sensen Wu, Guifen Wu, Yifeng Wu, Pin Wu, Tzu-Chun Wu, Qingping Wu, R M Wu, Mian Wu, S J Wu, Senquan Wu, Haisu Wu, Jingjing Wu, Cheng Wu, Meng Wu, Geping Wu, Yu Wu, Yumin Wu, Xia Wu, Xian-Run Wu, William Ka Kei Wu, Juan Wu, Pei-Ei Wu, Meng-Hsun Wu, Yingying Wu, S M Wu, Xiangwei Wu, Guangrun Wu, Liuxin Wu, Yangyu Wu, Jia-Hui Wu, Jin-Zhen Wu, S L Wu, Shaohuan Wu, Yanli Wu, June K Wu, Haishan Wu, H Wu, Zhou-Ming Wu, Deqing Wu, Tao Wu, Dong-Bo Wu, Binxin Wu, Yalan Wu, Xiangxin Wu, Xueji Wu, Hongxi Wu, Zhonghui Wu, Jiaxi Wu, Tianzhi Wu, Meiqi Wu, Weiwei Wu, Yan-Jun Wu, Lijuan Wu, Tingqin Wu, Jianming Wu, P L Wu, Yih-Ru Wu, Lanlan Wu, Jianjun Wu, Jianguang Wu, An-Xin Wu, Xingjie Wu, Jianzhang Wu, Xianan Wu, Wei-Ping Wu, Haoan Wu, Fang-Tzu Wu, Wenwen Wu, Zhongjun Wu, Xi Wu, Teng Wu, Xiaoling Wu, Mengjuan Wu, Wen Wu, Yifan Wu, Yang Wu, Qianhu Wu, Shenyue Wu, Wu-Tian Wu, Qianwen Wu, Ye Wu, Lixing Wu, Gui-Qin Wu, Grace F Wu, Xing-Ping Wu, Ming Wu, Lisha Wu, Yanchuan Wu, Siqi Wu, Yuming Wu, Yuan Wu, Yu-Ting Wu, I H Wu, Hailong Wu, Minghua Wu, B Wu, Zhenlong Wu, Fang Wu, Guanzhong Wu, Liqun Wu, Guifu Wu, Chris Y Wu, Zhikang Wu, Qi-Yong Wu, Qingshi Wu, Zhao-Yang Wu, Chih-Ching Wu, Man-Jing Wu, Jun Wu, Jinhui Wu, Jincheng Wu, Linhong Wu, Hung-Tsung Wu, Tangchun Wu, Xinglong Wu, Zhen-Yang Wu, Ma Wu, Jiu-Lin Wu, Dongyan Wu, Yin Wu, Yong Wu, Yan Wu, Weizhen Wu, Changyu Wu, Fanggeng Wu, Dishan Wu, Yue Wu, Yi-Long Wu, Ge-ru Wu, Jinqiao Wu, Jing-Wen Wu, Zhongyang Wu, Lifang Wu, Jia-Wei Wu, Sheng-Li Wu, Songfen Wu, Yihan Wu, Kebang Wu, Wenyong Wu, Cai-Qin Wu, Yilong Wu, Hsiu-Chuan Wu, Yanan Wu, Xueqian Wu, Yen-Wen Wu, Paul W Wu, Xing-De Wu, Ying-Ting Wu, Mingfu Wu, Yucan Wu, Na-Qiong Wu, Jinze Wu, Linzhi Wu, Xuhan Wu, H J Wu, Ruize Wu, Dirong Wu, Chung-Yi Wu, Yaohong Wu, Jianyi Wu, Jugang Wu, Jiao Wu, Liang-Huan Wu, Xueling Wu, Ruying Wu, Gen Sheng Wu, Zhaoyuan Wu, Shiwen Wu, Andong Wu, Yu-Ling Wu, Hsan-Au Wu, Jia-Qi Wu, Yanting Wu, Xihai Wu, Lulu Wu, Xuxian Wu, Xiaomei Wu, Jingyue Wu, Shuihua Wu, Ren Wu, S Wu, Yupeng Wu, Haoming Wu, Samuel M Wu, Fan Wu, Yuesheng Wu, Tiange Wu, Yihe Wu, Shuang Wu, Jiayu Wu, Chia-Lung Wu, Shengnan Wu, Yaojiong Wu, Y Wu, Y Y Wu, Zhuoze Wu, Zimu Wu, Depei Wu, Yi-Hua Wu, Haiyun Wu, Yanyan Wu, Min Wu, Wenjuan Wu, Guangxi Wu, Jinfeng Wu, Junjie Wu, Yawen Wu, Pinglian Wu, Hui-Hui Wu, Xunwei Wu, Xuefeng Wu, Constance Wu, Depeng Wu, Dianqing Wu, Qibiao Wu, Nan Wu, Hao-Tian Wu, Hanyu Wu, Xiaojiang Wu, Cheng-Jun Wu, San-pin Wu, Xiaofan Wu, Xiwei Wu, Shi-Xin Wu, Shao-Guo Wu, Sunyi Wu, Yueheng Wu, Chengqian Wu, Kuixian Wu, Xin-Xi Wu, Guanyi Wu, Qiuxia Wu, Danhong Wu, Zhong-Jun Wu, Siyi Wu, He Wu, Xiangsheng Wu, Kaili Wu, Lanxiang Wu, Liting Wu, Ping-Hsun Wu, Zheng Wu, Wen-Ling Wu, Jiang-Nan Wu, Huanlin Wu, Yongfei Wu, Catherine A Wu, Leslie Wu, Shuo Wu, Peng-Fei Wu, Cho-Kai Wu, Meng-Han Wu, Hon-Yen Wu, Anguo Wu, Yuguang Philip Wu, Hai-Yin Wu, Yicheng Wu, Xiaolang Wu, Yujie Wu, Qing Wu, V C Wu, Haomin Wu, Xingdong Wu, Hengyu Wu, Jiang Wu, Xiaoli Wu, Chengxi Wu, Junyi Wu, Ling-qian Wu, William K K Wu, Chun Wu, Lesley Wu, Niting Wu, Jiayuan Wu, Xueying Wu, Yingning Wu, S-F Wu, David Wu, Jin-Shang Wu, Mei-Na Wu, Joshua L Wu, Guanzhao Wu, Jianqiang Wu, Runda Wu, Li-Hsien Wu, Rongjie Wu, June-Hsieh Wu, Huazhang Wu, Huanwen Wu, Xiu-Zhi Wu, Yanran Wu, Xianfeng Wu, Weibin Wu, Xuanshuang Wu, Yan Yan Wu, G X Wu, Runpei Wu, Chien-Ting Wu, Jiaqi Wu, Li-Na Wu, Qinfeng Wu, Chia-Chang Wu, Yueming Wu, Siyu Wu, Renhai Wu, Baojian Wu, Yi-Xia Wu, Renrong Wu, C-H Wu, Wei-Yin Wu, Chuan-Ling Wu, Xinran Wu, Fengying Wu, Qiuliang Wu, Guanhui Wu, Jinjie Wu, Wei-Chi Wu, Wei-Xun Wu, Meng-Na Wu, Lin Wu, Wan-Fu Wu, Jiajing Wu, Colin Chih-Chien Wu, Yajie Wu, Qiaowei Wu, Yaru Wu, Xiaoping Wu, Xue-Yan Wu, Mengchao Wu, Weijun Wu, Boquan Wu, Zelai Wu, Chunyan Wu, Pei-Wen Wu, Guojun Wu, Yichen Wu, Ming-Tao Wu, Hsueh-Erh Wu, Guang-Bo Wu, Zhi-Yong Wu, Chia-Zhen Wu, Kay L H Wu, Yong-Hong Wu, Anping Wu, Jiahang Wu, Xiaobin Wu, Ching-Yi Wu, Linzhen Wu, Xiaoxing Wu, Haidong Wu, Zhen-Qi Wu, Mark N Wu, Jianmin Wu, Guanrong Wu, Xianpei Wu, Yanchun Wu, An-Dong Wu, Dongsheng Wu, Ren-Chin Wu, Yuchen Wu, Mengna Wu, Lijun Wu, Zhuanbin Wu, Yanjing Wu, Haodi Wu, Lun Wu, Si-Jia Wu, Yongfa Wu, Ximei Wu, Hai-Ping Wu, Xiangping Wu, Wenyu Wu, L-F Wu, Yixia Wu, Haiying Wu, Yiran Wu, Yanhong Wu, Xiayin Wu, Yushun Wu, Yali Wu, Qitian Wu, Qin Wu, Xiaofu Wu, Jiamei Wu, Xiaoyong Wu, Qiong Wu, Xiaoying Wu, Wujun Wu, Peiyi Wu, N Wu, Yongmei Wu, Xiaojing Wu, Yizhou Wu, Dan Wu, Wen-Qiang Wu, Anshi Wu, Junqing Wu, Xiao-Yang Wu, Zhaoxia Wu, Liyang Wu, Hongke Wu, Mengqiu Wu, Peng Wu, Haibin Wu, Ding Lan Wu, Lecheng Wu, Yingzhi Wu, Kejia Wu, Anyi Wu, Junshu Wu, Jianxin Wu, Deguang Wu, Jiaxuan Wu, W Wu, Justin C Y Wu, Jiong Wu, Yu-Chih Wu, Qinglan Wu, Xinyi Wu, Diana Wu, Zhongluan Wu, Xuefen Wu, Yanqiong Wu, Shengming Wu, Jian-Lin Wu, Donglin Wu, Daren Wu, Lintao Wu, Xiaodong Wu, Chang-Jiun Wu, Chunshuai Wu, Irene X Y Wu, Yaping Wu, Yangna Wu, Xiping Wu, Chia-Chen Wu, Zongheng Wu, Wenyi Wu, Yansheng Wu, Shaojun Wu, Aimin Wu, Caisheng Wu, Xu Wu, Zhongchan Wu, Fei Wu, Yaohua Wu, Yibo Wu, Qinyi Wu, Zhengyu Wu, Yadi Wu, Hang Wu, L Wu, Mingjun Wu, Yuetong Wu, Wen-Juan Wu, Guangming Wu, Lingzhi Wu, Tingting Wu, Zhong-Yan Wu, Zhuzhu Wu, Yuanbing Wu, Cuiyan Wu, Baoqin Wu, Colin O Wu, Shuyan Wu, Hongmei Wu, Guangsen Wu, Xiaolin Wu, An Guo Wu, Kailang Wu, Chien-Sheng Wu, Chun-Hua Wu, Jemma X Wu, Wenqi Wu, Quanhui Wu, Qing-Wu Wu, Yanxiang Wu, Jiajin Wu, Yuan Kai Wu, Qiao Wu
articles
Chao Wei, Jing Liu, Bing Wu +8 more · 2025 · Brain, behavior, and immunity · Elsevier · added 2026-04-24
Accumulating evidence indicates that neuroinflammation is involved in the pathogenesis of Alzheimer's disease (AD). According to RNA sequencing and quantitative PCR (qPCR), we found that chemokine CCL Show more
Accumulating evidence indicates that neuroinflammation is involved in the pathogenesis of Alzheimer's disease (AD). According to RNA sequencing and quantitative PCR (qPCR), we found that chemokine CCL3 mRNA expression was abnormally upregulated in the brains of AD transgenic mice. Moreover, the levels of CCL3 in the serum of AD patients were significantly elevated and negatively correlated with their cognitive abilities. However, the role of CCL3 in AD neuroinflammation and pathological damages remains elusive. Using behavioral, histological, and biochemical methods, outcomes of CCL3 antibody treatment on neuropathology and cognitive deficits were studied in the APPswe/PS1dE9 mice. In the present study, we reported that CCL3 protein expression was increased in the APPswe/PS1dE9 mice, whereas blockage of CCL3 with neutralizing antibody potently inhibited CCL3 activation in the APPswe/PS1dE9 mice down to the levels of wild-type mice. Specifically, CCL3 antibody significantly improved the learning and memory abilities of APPswe/PS1dE9 mice. In addition, CCL3 antibody treatment decreased cerebral amyloid-β (Aβ) levels and plaque burden via inhibiting amyloid precursor protein (APP) processing by reducing beta-site APP cleaving enzyme 1 (BACE1) expression in the APPswe/PS1dE9 mice. We also found that CCL3 antibody treatment alleviated neuroinflammation and reduced synaptic defects in the APPswe/PS1dE9 mice. Furthermore, the activated NF-κB signaling pathway in APPswe/PS1dE9 mice was inhibited by CCL3 antibody treatment. Collectively, our findings provide evidence that CCL3 activation may contribute to the AD pathogenesis and may serve as a novel therapeutic target in the treatment of AD. Show less
no PDF DOI: 10.1016/j.bbi.2025.04.034
BACE1
Danlei Bi, Hong Bao, Xiaoli Yang +18 more · 2025 · Neuron · Elsevier · added 2026-04-24
Neural hyperexcitability has been clinically associated with amyloid-β (Aβ) pathology and cognitive impairment in Alzheimer's disease (AD). Here, we show that decreased GABA
no PDF DOI: 10.1016/j.neuron.2025.01.030
BACE1
Fahad Hussain, Ayesha Tahir, Hafiz Muzzammel Rehman +3 more · 2025 · European journal of medicinal chemistry · Elsevier · added 2026-04-24
Alzheimer's disease (AD) is marked by low neurotransmitter levels, inflammation, increased oxidative stress, and the aggregation of amyloid-β and tau proteins. The development of hybrid compounds acti Show more
Alzheimer's disease (AD) is marked by low neurotransmitter levels, inflammation, increased oxidative stress, and the aggregation of amyloid-β and tau proteins. The development of hybrid compounds acting as multi-target-directed ligands (MTDLs) is a novel and contemporary approach in Alzheimer's disease therapeutics. The objective of our current research focuses on identifying compounds with balanced, even moderate inhibition potential against multiple targets associated with cholinergic deficit and neuroinflammation. Inspired by our previous study, the thiazolidinedione-thiazole-based framework has been employed to design and synthesize a series of new hybrids. The inhibitory effects of the synthesized compounds on selected enzymes were investigated by employing in-vitro methods. The synergistic inhibition of acetylcholinesterase (AChE), monoamine oxidase-B (MAO-B), β-secretase (BACE-1), cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) by compound 49 is believed to have a more potent effect in treating Alzheimer's disease. Enzyme kinetic studies and their effect on substrate-enzyme interactions of the compounds with significant inhibitory potency for AChE and MAO-B were also investigated. Central nervous system (CNS) penetration was determined using in-vitro PAMPA assay. A neurotoxicity test on neuroblastoma cell lines (SH-SY5Y) showed that the compounds were non-toxic. Compound 49 showed an excellent neuroprotective effect by significantly reducing H Show less
no PDF DOI: 10.1016/j.ejmech.2025.117327
BACE1
Zhuoze Wu, Xiaojie Liu, Yuntai Wang +3 more · 2025 · Neuroscience bulletin · Springer · added 2026-04-24
Alzheimer's disease (AD), a neurodegenerative disorder with complex etiologies, manifests through a cascade of pathological changes before clinical symptoms become apparent. Among these early changes, Show more
Alzheimer's disease (AD), a neurodegenerative disorder with complex etiologies, manifests through a cascade of pathological changes before clinical symptoms become apparent. Among these early changes, alterations in the expression of non-coding RNAs (ncRNAs) have emerged as pivotal events. In this study, we focused on the aberrant expression of ncRNAs and revealed that Lamr1-ps1, a pseudogene of the laminin receptor, significantly exacerbates early spatial learning and memory deficits in APP/PS1 mice. Through a combination of bioinformatics prediction and experimental validation, we identified the miR-29c/Bace1 pathway as a potential regulatory mechanism by which Lamr1-ps1 influences AD pathology. Importantly, augmenting the miR-29c-3p levels in mice ameliorated memory deficits, underscoring the therapeutic potential of targeting miR-29c-3p in early AD intervention. This study not only provides new insights into the role of pseudogenes in AD but also consolidates a foundational basis for considering miR-29c as a viable therapeutic target, offering a novel avenue for AD research and treatment strategies. Show less
📄 PDF DOI: 10.1007/s12264-024-01336-6
BACE1
Qiuyun Tian, Junjie Li, Bin Wu +16 more · 2025 · The Journal of clinical investigation · added 2026-04-24
Posttranslational modification (PTM) of the amyloid precursor protein (APP) plays a critical role in Alzheimer's disease (AD). Recent evidence reveals that lactylation modification, as a novel PTM, is Show more
Posttranslational modification (PTM) of the amyloid precursor protein (APP) plays a critical role in Alzheimer's disease (AD). Recent evidence reveals that lactylation modification, as a novel PTM, is implicated in the occurrence and development of AD. However, whether and how APP lactylation contributes to both the pathogenesis and cognitive function in AD remains unknown. Here, we observed a reduction in APP lactylation in AD patients and AD model mice and cells. Proteomic mass spectrometry analysis further identified lysine 612 (APP-K612la) as a crucial site for APP lactylation, influencing APP amyloidogenic processing. A lactyl-mimicking mutant (APPK612T) reduced amyloid-β peptide (Aβ) generation and slowed down cognitive deficits in vivo. Mechanistically, APPK612T appeared to facilitate APP trafficking and metabolism. However, lactylated APP entering the endosome inhibited its binding to BACE1, suppressing subsequent cleavage. Instead, it promoted protein interaction between APP and CD2-associated protein (CD2AP), thereby accelerating the endosomal-lysosomal degradation pathway of APP. In the APP23/PS45 double-transgenic mouse model of AD, APP-Kla was susceptible to L-lactate regulation, which reduced Aβ pathology and repaired spatial learning and memory deficits. Thus, these findings suggest that targeting APP lactylation may be a promising therapeutic strategy for AD in humans. Show less
📄 PDF DOI: 10.1172/JCI184656
BACE1
Zhengyu Wang, Dan Wu, Xinyi Hu +5 more · 2025 · Journal of ethnopharmacology · Elsevier · added 2026-04-24
Chronic sleep deprivation (CSD) can result in neuronal damage, synaptic dysfunction, Aβ production, neuroinflammation, and ultimately cognitive deterioration. WuYou Decoction (WYD), a contemporary pre Show more
Chronic sleep deprivation (CSD) can result in neuronal damage, synaptic dysfunction, Aβ production, neuroinflammation, and ultimately cognitive deterioration. WuYou Decoction (WYD), a contemporary prescription, has shown promise in enhancing sleep quality and cognitive performance in individuals with insomnia. However, the specific molecular mechanisms responsible for the neuroprotective effects of WYD on CSD remain incompletely understood. This study aimed to investigate the neuroprotective effects of WYD on the CSD model and its molecular mechanism. UHPLC-MS/MS analysis was utilized to analyze the active ingredients of WYD extract. The study employed the multi-platform water environment method to establish the CSD model in rats. Subsequent to treatment with varying doses of WYD in CSD rats, cognitive function and pathological alterations in hippocampus and cortex, including neuronal damage, synaptic dysfunction, Aβ production, and neuroinflammation, were evaluated through a combination of Morris Water Maze test, HE staining, Nissl staining, Golgi-Cox staining, Transmission electron microscope, ELISA, Immunohistochemistry staining, Immunofluorescence staining and Western blot. UHPLC-MS/MS analysis revealed a total of 99 active ingredients were identified from the WYD extract. The administration of WYD exhibited a mitigation of cognitive decline in the model of CSD, as evidenced by increased neuron count in the hippocampus and cortex, and improved density and length of dendritic spines in these brain regions. Furthermore, WYD was found to suppress the Aβ production, and inhibit the expression of BACE1, PS1, GFAP, IBA1, IL-1β, IL-6, TNF-α, phosphorylated IκBα (Ser32) and phosphorylated NF-κB p65 (Ser536) in the hippocampus and cortex, while also increasing the levels of PSD95, SYN1, ADAM10, IDE, SIRT1 and Nrf2. WYD exhibits neuroprotective properties in CSD, potentially through modulation of the Aβ-related enzymes and SIRT1/Nrf2/NF-κB pathway. Show less
no PDF DOI: 10.1016/j.jep.2024.118939
BACE1
Yisheng Chen, Xiaofeng Chen, Zhiwen Luo +16 more · 2025 · Journal of advanced research · Elsevier · added 2026-04-24
Alzheimer's Disease (AD), a progressive neurodegenerative disorder, is marked by cognitive deterioration and heightened neuroinflammation. The influence of Insulin-like Growth Factor 1 Receptor (IGF1R Show more
Alzheimer's Disease (AD), a progressive neurodegenerative disorder, is marked by cognitive deterioration and heightened neuroinflammation. The influence of Insulin-like Growth Factor 1 Receptor (IGF1R) and its post-translational modifications, especially sumoylation, is crucial in understanding the progression of AD and exploring novel therapeutic avenues. This study investigates the impact of exercise on the sumoylation of IGF1R and its role in ameliorating AD symptoms in APP/PS1 mice, with a specific focus on neuroinflammation and innovative therapeutic strategies. APP/PS1 mice were subjected to a regimen of moderate-intensity exercise. The investigation encompassed assessments of cognitive functions, alterations in hippocampal protein expressions, neuroinflammatory markers, and the effects of exercise on IGF1R and SUMO1 nuclear translocation. Additionally, the study evaluated the efficacy of KPT-330, a nuclear export inhibitor, as an alternative to exercise. Exercise notably enhanced cognitive functions in AD mice, possibly through modulations in hippocampal proteins, including Bcl-2 and BACE1. A decrease in neuroinflammatory markers such as IL-1β, IL-6, and TNF-α was observed, indicative of reduced neuroinflammation. Exercise modulated the nuclear translocation of SUMO1 and IGF1R in the hippocampus, thereby facilitating neuronal regeneration. Mutant IGF1R (MT IGF1R), lacking SUMO1 modification sites, showed reduced SUMOylation, leading to diminished expression of pro-inflammatory cytokines and apoptosis. KPT-330 impeded the formation of the IGF1R/RanBP2/SUMO1 complex, thereby limiting IGF1R nuclear translocation, inflammation, and neuronal apoptosis, while enhancing cognitive functions and neuron proliferation. Moderate-intensity exercise effectively mitigates AD symptoms in mice, primarily by diminishing neuroinflammation, through the reduction of IGF1R Sumoylation. KPT-330, as a potential alternative to physical exercise, enhances the neuroprotective role of IGF1R by inhibiting SUMOylation through targeting XPO1, presenting a promising therapeutic strategy for AD. Show less
📄 PDF DOI: 10.1016/j.jare.2024.03.025
BACE1
Qinfei Zhao, Weiquan Hu, Yu Xia +7 more · 2025 · Scientific reports · Nature · added 2026-04-24
Osteosarcoma, an aggressive bone malignancy predominantly affecting children and adolescents, is characterized by a poor prognosis and high mortality rates. The development of reliable prognostic tool Show more
Osteosarcoma, an aggressive bone malignancy predominantly affecting children and adolescents, is characterized by a poor prognosis and high mortality rates. The development of reliable prognostic tools is critical for advancing personalized treatment strategies. However, identifying robust gene signatures to predict osteosarcoma outcomes remains a significant challenge. In this study, we analyzed gene expression data from 138 osteosarcoma samples across two multicenter cohorts and identified 14 consensus prognosis-associated genes via univariate Cox regression analysis. Using 66 combinations of 10 machine learning (ML) algorithms, we developed a machine learning-derived prognostic signature (MLDPS) optimized by the average C-index across TARGET, GSE21257, and merged cohorts. The MLDPS effectively stratified osteosarcoma patients into high- and low-risk score groups, achieving strong predictive performance for 1-, 3-, and 5-year overall survival (AUC range: 0.852 - 0.963). The MLDPS, comprising seven genes (CTNNBIP1, CORT, DLX2, TERT, BBS4, SLC7A1, NKX2-3), exhibited superior predictive accuracy compared to 10 established gene signatures. The findings of the MLDPS carry significant clinical implications for osteosarcoma treatment. Patients with a high-risk score demonstrated worse prognosis, increased metastasis risk, reduced immune infiltrations, and greater sensitivity to immunotherapy. Conversely, low-risk patients exhibited prolonged survival and distinct drug sensitivities. These findings underscore the potential of MLDPS to guide risk stratification, inform personalized therapeutic strategies, and improve clinical management in osteosarcoma. Show less
📄 PDF DOI: 10.1038/s41598-025-00179-z
BBS4
Zehan Li, Huazhen Wu, Chuzhong Wei +15 more · 2025 · 3 Biotech · Springer · added 2026-04-24
By integrating single-cell and bulk RNA-sequencing data for esophageal cancer (ESCA), we developed and validated a seven-macrophage-gene prognostic signature (FCN1, SCARB2, ATF5, PHLDA2, GLIPR1, CHORD Show more
By integrating single-cell and bulk RNA-sequencing data for esophageal cancer (ESCA), we developed and validated a seven-macrophage-gene prognostic signature (FCN1, SCARB2, ATF5, PHLDA2, GLIPR1, CHORDC1, and BCKDK). This signature effectively stratified patients into high- and low-risk groups with significantly different overall survival, achieving area under the curve (AUC) values greater than 0.7 for 1-, 2-, and 3-year survival prediction. A high-risk status correlated with an immunosuppressive tumor microenvironment, characterized by lower infiltration of B cells and CD8 + T cells, and was associated with reduced sensitivity to multiple chemotherapeutic agents, including Cisplatin and 5-Fluorouracil. Conversely, a low-risk status was linked to greater immune cell infiltration and higher predicted chemosensitivity. At the single-cell level, pseudotime analysis revealed that macrophage maturation significantly correlated with a decreasing risk score, suggesting that mature macrophages may contribute to a favorable prognosis. Furthermore, cell communication analysis identified high-risk macrophages as dominant drivers of a pro-tumorigenic microenvironment via signaling pathways, such as SPP1 and complement. In conclusion, this seven-gene signature is a robust prognostic biomarker that offers a new strategy for personalized risk assessment and treatment selection in ESCA. The online version contains supplementary material available at 10.1007/s13205-025-04452-w. Show less
no PDF DOI: 10.1007/s13205-025-04452-w
BCKDK
Caifeng Shi, Xingyue Wang, Songyan Qin +16 more · 2025 · Diabetologia · Springer · added 2026-04-24
Kidney tubular cell injury is largely responsible for the pathophysiological features of diabetic kidney disease (DKD). Increased leucine levels in individuals with DKD have been associated with the p Show more
Kidney tubular cell injury is largely responsible for the pathophysiological features of diabetic kidney disease (DKD). Increased leucine levels in individuals with DKD have been associated with the progression of diabetes to end-stage renal failure, yet a comprehensive understanding of leucine metabolism in kidney tubules during the progression of DKD is lacking. Human kidney biopsies and mouse models were used to assess leucine metabolism during DKD progression. Enhancement of leucine degradation was achieved through genetic ablation or pharmacological inhibition of branched-chain ketoacid dehydrogenase kinase (BCKDK). Cultured kidney tubular epithelial cells were used to analyse the underlying cellular mechanisms. The association of urinary leucine with progression of DKD was determined in individuals with diabetes. Measurements of metabolites and enzymes suggested defective leucine degradation and increased BCKDK expression in kidney tubules during DKD progression. Enhancement of leucine degradation relieved glucose-induced metabolic remodelling in tubular cells and mitigated DKD in mouse models. Accumulation of leucine stimulated metabolic remodelling via the mTOR signalling pathway; this was relieved by blocking leucine uptake or enhancing its degradation. Restricting dietary leucine significantly decreased albuminuria, kidney hypertrophy and lipid accumulation in mouse models of diabetes. Additionally, we observed that rapid decline in kidney function correlated with a higher urinary leucine-to-creatinine ratio in both female and male individuals with diabetes. In summary, we identify defective leucine degradation in renal tubules of diabetic individuals and propose leucine as a causative factor for DKD, highlighting its potential as a therapeutic target for further investigation. The transcriptomic data supporting the findings of this study are openly available at the National Center for Biotechnology Information Sequence ReadArchive (SRA) ( https://www.ncbi.nlm.nih.gov/sra , identifiers: PRJNA1180888 and PRJNA1180923). The metabolomics data associated with the manuscript are available in the ESM. Show less
📄 PDF DOI: 10.1007/s00125-025-06519-y
BCKDK
Hao Wu, Jiajia Yang, Zixia Yang +8 more · 2025 · Cell death and differentiation · Nature · added 2026-04-24
The protein branched-chain ketoacid dehydrogenase kinase (BCKDK), which regulates the metabolism of branched-chain amino acids, has recently been implicated in tumor progression. However, the role of Show more
The protein branched-chain ketoacid dehydrogenase kinase (BCKDK), which regulates the metabolism of branched-chain amino acids, has recently been implicated in tumor progression. However, the role of BCKDK in lung cancer remains largely unexplored. In this study, we explored the mechanisms by which BCKDK influences lung cancer progression and contributes to drug resistance. By integrating single-cell RNA and bulk RNA sequencing data from lung cancer patients, we identified BCKDK as a novel gene related to malignant epithelial cells, involved in tumor initiation and associated with poor patient prognosis. Subsequently, through a series of molecular biology experiments, we demonstrated that BCKDK promotes aerobic glycolysis, Trametinib resistance, and tumor progression in lung cancer by upregulating MYC transcription. Mechanistically, BCKDK interacts with BCLAF1 to promote its phosphorylation at the serine 285 site. This modification facilitates BCLAF1 binding to the MYC promoter, thereby enhancing MYC transcription. Subsequently, elevated MYC levels upregulate hexokinase 2, promoting aerobic glycolysis and lung cancer progression. In addition, the elevated glycolysis product, lactate, promotes Trametinib resistance by upregulating the ABC transporters. Taken together, our data identify BCKDK as a novel regulator of aerobic glycolysis that promotes lung cancer progression and Trametinib resistance through the BCKDK/BCLAF1/MYC/HK2 axis. Targeting BCKDK in combination with Trametinib may offer a promising treatment for lung cancer. Graphical representation of the BCKDK/BCLAF1/MYC/HK2 axis and its role in Trametinib resistance and lung cancer progression. Created with BioRender.com. Show less
no PDF DOI: 10.1038/s41418-025-01531-6
BCKDK
Zheyi Wang, Yize Sun, Zetai Bai +3 more · 2025 · Movement disorders : official journal of the Movement Disorder Society · Wiley · added 2026-04-24
Mitochondrial dysfunction is increasingly recognized as a key factor in neurodegenerative diseases (NDDs), underscoring the therapeutic potential of targeting mitochondria-related genes. This study ai Show more
Mitochondrial dysfunction is increasingly recognized as a key factor in neurodegenerative diseases (NDDs), underscoring the therapeutic potential of targeting mitochondria-related genes. This study aimed to identify novel biomarkers and drug targets for these diseases through a comprehensive analysis that integrated genome-wide Mendelian randomization (MR) with genes associated with mitochondrial function. Using existing publicly available genome-wide association studies (GWAS) summary statistics and comprehensive data on 1136 mitochondria-related genes, we initially identified a subset of genes related to mitochondrial function that exhibited significant associations with NDDs. We then conducted colocalization and summary-data-based Mendelian randomization (SMR) analyses using expression quantitative trait loci (eQTL) to validate the causal role of these candidate genes. Additionally, we assessed the druggability of the encoded proteins to prioritize potential therapeutic targets for further exploration. Genetically predicted levels of 10 genes were found to be significantly associated with the risk of NDDs. Elevated DMPK and LACTB2 levels were associated with increased Alzheimer's disease risk. Higher expression of NDUFAF2, BCKDK, and MALSU1, along with lower TTC19, raised Parkinson's disease risk. Higher ACLY levels were associated with both amyotrophic lateral sclerosis and multiple sclerosis (MS) risks, while decreased MCL1, TOP3A, and VWA8 levels raised MS risk. These genes primarily impact mitochondrial function and energy metabolism. Notably, several druggable protein targets identified are being explored for potential NDDs treatment. This data-driven MR study demonstrated the causal role of mitochondrial dysfunction in NDDs. Additionally, this study identified candidate genes that could serve as potential pharmacological targets for the prevention and treatment of NDDs. © 2025 International Parkinson and Movement Disorder Society. Show less
no PDF DOI: 10.1002/mds.30123
BCKDK
Ming Gao, Qiongqiong Wan, Shibo Zhou +3 more · 2025 · Journal of the American Chemical Society · ACS Publications · added 2026-04-24
Protein lysine methacrylation (Kmea) is a recently identified post-translational modification whose biofunction remains poorly understood. Until now, there has been no chemical labeling method for Kme Show more
Protein lysine methacrylation (Kmea) is a recently identified post-translational modification whose biofunction remains poorly understood. Until now, there has been no chemical labeling method for Kmea modification, which has severely hindered the discovery and functional studies of methacrylated proteins. Here, we developed a photocatalytic thia-Michael reaction system for the chemoselective labeling of protein methacrylation. By exploiting the dual effect of steric hindrance and the stability of the generated C-center radical, the reaction interference of the structural isomer crotonylation can be efficiently avoided. Based on this reaction, a multifunctional water-soluble benzenethiol-azide probe azDSH was designed and synthesized, and a workflow for the specific labeling, enrichment, and identification of Kmea proteins was developed. Proteomic identification of histone and nuclear protein extracts and whole-cell lysate revealed a number of novel Kmea proteins and modification sites besides histones, such as HMGB1, TdIF2, UHRF1, HNRPD, BRWD1, TAF1, TACC1, and SETD3, providing new targets for the study of epigenetic regulation. This study provides an effective method for the analysis of protein methacrylation modifications in biological systems. Show less
no PDF DOI: 10.1021/jacs.5c13826
BRWD1
Yicun Li, Yun Wu, Xiaolian Li +4 more · 2025 · Scientific reports · Nature · added 2026-04-24
Head and neck squamous cell carcinoma (HNSCC) poses a global health challenge. The management of HNSCC is complicated by the difficulty in detecting occult lymph node metastases, leading to dilemmas i Show more
Head and neck squamous cell carcinoma (HNSCC) poses a global health challenge. The management of HNSCC is complicated by the difficulty in detecting occult lymph node metastases, leading to dilemmas in elective neck dissection decisions, which will impair patients' quality of life without improving survival for nodal negative patients. We conducted a comparative analysis of the clinical features, genomic alterations, gene expression and methylation, tumor microenvironment and cellular states between the clinically N0 and pathologically N0 (cN0-pN0) patients and occult lymph node metastatic patients. Patients with occult lymph node metastases typically present with more poorly differentiated primary tumors and higher rates of angiolymphatic and perineural invasion. We identified a distinctive genomic mutation spectrum in the primary tumors of patients with occult metastases, notably in genes such as NSD1, ARHGAP15 and SMARCA4. A whole-genome DNA hypomethylation and altered gene expression profiles are identified in occult lymph node metastatic patients. Analysis of the tumor microenvironment revealed an enrichment of CARNS1 + NK cells and CBX1 + tumor cells in occult metastatic patients. In conclusion, patients with occult lymph node metastases exhibit distinct molecular and clinical features compared with cN0-pN0 patients. Show less
📄 PDF DOI: 10.1038/s41598-025-10320-7
CBX1
Yusong Han, Jia Chen, Shan Feng +1 more · 2025 · Organic & biomolecular chemistry · Royal Society of Chemistry · added 2026-04-24
Cyclic peptides exhibit important biological activities and are widely found in natural products and peptide-based drugs. Therefore, the development of synthesis methods for cyclic peptides is essenti Show more
Cyclic peptides exhibit important biological activities and are widely found in natural products and peptide-based drugs. Therefore, the development of synthesis methods for cyclic peptides is essential. In recent years, tryptophan-mediated cyclic peptides have emerged as bioactive molecules, but current methods require unique unnatural amino acids and transition metals as catalysts. Our group recently reported a tryptophan site-selective crosslinking in the protein binding pocket by sulfonium peptide Show less
no PDF DOI: 10.1039/d5ob00776c
CBX1
Huimin Yu, Shihong Li, Jian Wu +1 more · 2025 · Frontiers in genetics · Frontiers · added 2026-04-24
Breast cancer (BC) is one of the most prevalent malignant diseases affecting women. Cytochrome c (Cyt c) plays a critical role in various pathological processes, however, its precise mechanism in BC r Show more
Breast cancer (BC) is one of the most prevalent malignant diseases affecting women. Cytochrome c (Cyt c) plays a critical role in various pathological processes, however, its precise mechanism in BC remains unclear. This study aimed to identify prognostic genes linked to Cyt c in BC and explore their underlying mechanisms. Transcriptome data related to BC were initially obtained from TCGA and GEO database. Prognostic genes were identified through differential expression analysis, univariate Cox regression, and LASSO analysis. A risk model was subsequently developed and validated. Additionally, enrichment analysis, immune microenvironment analysis, and the construction of a TFs-mRNA network were conducted. Finally, the expression levels of prognostic genes were examined in both tumor and normal tissue samples, with confirmation through RT-qPCR. Eight prognostic genes ( Show less
📄 PDF DOI: 10.3389/fgene.2025.1627134
CETP
Huijing Shao, Chang Xu, Caihong Zhang +4 more · 2025 · International journal of women's health · added 2026-04-24
Dyslipidemia is linked to pregnancy complications, but its causal role remains uncertain. This two-sample Mendelian Randomization (MR) study investigated the causal relationship between lipid traits a Show more
Dyslipidemia is linked to pregnancy complications, but its causal role remains uncertain. This two-sample Mendelian Randomization (MR) study investigated the causal relationship between lipid traits and pregnancy complications and evaluated the impact of lipid-modifying drug targets. Genetic instruments for lipid traits and targets for lipid-modifying drugs were obtained from the Global Lipids Genetics Consortium. Three pregnancy complications' summary statistics came from the FinnGen R9 database. Significant drug targets underwent further analysis using Expression Quantitative Trait Loci data, and mediation analysis identified potential mediators. Increased high-density lipoprotein cholesterol (HDL-C) reduced the incidence of preeclampsia (OR: 0.755, 95% CI: 0.639-0.891, p=0.001, FDR=0.012) and gestational diabetes mellitus (GDM) (OR: 0.835, 95% CI: 0.741-0.942, p=0.003, FDR=0.018). Genetic proxies for cholesteryl ester transfer protein ( Elevated HDL-C levels help prevent preeclampsia and GDM. Show less
📄 PDF DOI: 10.2147/IJWH.S496268
CETP
Wenhui Hu, Han Feng, Ying Liu +8 more · 2025 · Human vaccines & immunotherapeutics · Taylor & Francis · added 2026-04-24
Cholesteryl ester transfer protein (CETP) plays a key role in lipoprotein metabolism, and its activity has been linked to the risk of atherosclerosis (AS). CETP inhibitors, such as obicetrapib, repres Show more
Cholesteryl ester transfer protein (CETP) plays a key role in lipoprotein metabolism, and its activity has been linked to the risk of atherosclerosis (AS). CETP inhibitors, such as obicetrapib, represent a novel approach in immunotherapy to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) by targeting lipid metabolism. In addition, CETP vaccines are being explored as a novel strategy for the prevention and treatment of ASCVD by inducing the body to produce antibodies against CETP, which is expected to reduce CETP activity, thereby increasing high-density lipoproteins (HDL) levels. This paper provides a comprehensive overview of the structure of CETP, the mechanisms of lipid transfer and the progress of immunotherapy in the last decade, which provides possible ideas for future development of novel drugs and optimization of immunization strategies. Show less
📄 PDF DOI: 10.1080/21645515.2025.2462466
CETP
Mei Wu, Qiannan Lin, Siyu Li +2 more · 2025 · Heliyon · Elsevier · added 2026-04-24
Observational studies suggest that blood lipids are a risk factor for uterine fibroids (UFs) and that lipid-lowering drugs are beneficial for the treatment and prevention of UF; however, the conclusio Show more
Observational studies suggest that blood lipids are a risk factor for uterine fibroids (UFs) and that lipid-lowering drugs are beneficial for the treatment and prevention of UF; however, the conclusions are inconsistent. We aimed to determine the causal effects of lipids and lipid-lowering drugs on UFs using Mendelian randomization (MR). Genetic variants from genome-wide association studies (GWAS) of lipid traits and variants in genes encoding lipid-lowering drug targets were extracted, and two independent UF GWAS were set as the outcome. Their effects on UF risk and related traits were estimated using the inverse variance weighted method. The MR analysis revealed that high density lipoprotein cholesterol (HDL-C, OR = 0.88, 95 % CI: 0.83-0.93, P = 3.58E-6) and triglycerides (TG, OR = 1.14, 95 % CI: 1.07-1.21, P = 6.83E-5) were protective factors and risk factors for UF, respectively. Drug-targeted MR analysis results indicated that genetically predicted inhibition of cholesteryl ester transfer protein (CETP) was associated with a lower UF risk (OR = 0.95, 95 % CI: 0.92-0.98, P = 7.83E-4), as well as reduced levels or risk of other UF-associated clinical traits, including estradiol level, excessive menstruation, abdominal and pelvic pain, myomectomy, and miscarriage. Our study provides evidence that HDL-C and TG levels were causally associated with UF risk. Genetically proxied CETP inhibition may have a protective effect against UF, which warrants further investigation. Show less
📄 PDF DOI: 10.1016/j.heliyon.2024.e41539
CETP
Jingbo Ma, Xuejuan Zi, Shuo Wu +6 more · 2025 · Bioresource technology · Elsevier · added 2026-04-24
A meta-analysis was conducted to assess the effects of citric acid (CA) on silage fermentation, and then used whole-plant cassava silage as a model to explore the underlying microbiological mechanisms Show more
A meta-analysis was conducted to assess the effects of citric acid (CA) on silage fermentation, and then used whole-plant cassava silage as a model to explore the underlying microbiological mechanisms with metagenomic and metabolomic data. The meta-analysis revealed that CA supplementation increased the dry matter, crude protein, water-soluble carbohydrate, and lactic acid contents in silage, but decreased the pH, dry matter loss, and the contents of fiber, NH Show less
no PDF DOI: 10.1016/j.biortech.2025.133025
CPS1
Stuti Bakshi, Taryn Diep, Brandon J Willis +13 more · 2025 · Disease models & mechanisms · added 2026-04-24
Carbamoyl phosphate synthetase 1 (CPS1) deficiency is a rare metabolic disorder that, in neonatal onset, is typically characterized by severe life-threatening and neurologically injuring hyperammonemi Show more
Carbamoyl phosphate synthetase 1 (CPS1) deficiency is a rare metabolic disorder that, in neonatal onset, is typically characterized by severe life-threatening and neurologically injuring hyperammonemic episodes with high unmet patient need. Patients that retain limited enzyme activity may present later in life with less severe hyperammonemia. CPS1 drives the first step in the urea cycle, the pathway terrestrial mammals utilize to metabolize nitrogen. In order to probe the effect of hyperammonemia on the developing nervous system and explore new therapies, a murine Cps1 exon 3-4 mutant was previously generated. However, these mice die within 24 h of birth, limiting study capabilities. Herein, we developed a novel Cps1 hypomorphic murine model with residual enzyme activity that maintains survival, but with dysfunction of Cps1 that could be detected biochemically. Characterization, based on the orthologous human variant Asn674Ile, revealed that the variant is reproducible, 100% penetrant and biochemically phenocopies the human disorder. The hypomorph presents with elevated ammonia and glutamate, and reduced citrulline, and with an impaired rate of ureagenesis, providing a novel platform to study and develop therapies for CPS1 deficiency. Show less
📄 PDF DOI: 10.1242/dmm.052303
CPS1
Yohan Jung, Harmony Grainger, Shizhuo Yang +4 more · 2025 · Frontiers in immunology · Frontiers · added 2026-04-24
The 2002 movie
📄 PDF DOI: 10.3389/fimmu.2025.1632283
DHX36
Qiong-Wen Lu, Shao-Yuan Liu, Xiu-Quan Liao +6 more · 2025 · Nucleic acids research · Oxford University Press · added 2026-04-24
Oocyte maturation-coupled mRNA post-transcriptional regulation is essential for the establishment of developmental potential. Previously, oocyte mRNA translation efficiencies focused on the trans-regu Show more
Oocyte maturation-coupled mRNA post-transcriptional regulation is essential for the establishment of developmental potential. Previously, oocyte mRNA translation efficiencies focused on the trans-regulation of key RNA-binding protein (RBPs), rarely related to RNA structure. RNA G-quadruplexes (rG4s) are four-stranded RNA secondary structures involved in many different aspects of RNA metabolism. In this study, we have developed a low-input technique for rG4 detection (G4-LACE-seq) in mouse oocytes and found that rG4s were widely distributed in maternal transcripts, with enrichment in untranslated regions, and they underwent transcriptome-wide removal during meiotic maturation. The rG4-selective small-molecule ligand BYBX stabilized rG4s in the oocyte transcriptome and impaired spindle assembly and meiotic cell cycle progression. The proteomic spectrum results revealed that rG4 accumulation weakened the binding of a large number of RBPs to mRNAs, especially those associated with translational initiation. Ribosomal immunoprecipitation and translational reporter assays further proved that rG4s in the untranslated regions negatively affected the translational efficiency of key maternal mRNAs. Overexpression DEAH/RHA family helicase-36 partially reverses BYBX-induced oocyte developmental defects, suggesting its importance in rG4 regulation. Collectively, this study describes the distribution, dynamic changes, and regulation of rG4s in the mouse maternal transcriptome. Before meiosis resumption, a large number of rG4s in oocytes are necessary to maintain the translatome at a low level, and DHX36-mediated rG4 removal promotes a translational switch and is required for successful maternal-to-zygotic transition. Show less
📄 PDF DOI: 10.1093/nar/gkaf067
DHX36
Qianqian Wang, Peize Chen, Xiaorong Wang +9 more · 2025 · Non-coding RNA research · Elsevier · added 2026-04-24
[This corrects the article DOI: 10.1016/j.ncrna.2022.12.004.].
no PDF DOI: 10.1016/j.ncrna.2025.02.002
DHX36
Yu-Xuan Jiao, Guo-Wei Bu, Yun-Wen Wu +6 more · 2025 · Science bulletin · Elsevier · added 2026-04-24
DHX36 plays a crucial role in regulating transcriptional and post-transcriptional processes through its interaction with G-quadruplexes (G4s). The mechanisms by which DHX36 regulates G4s vary across d Show more
DHX36 plays a crucial role in regulating transcriptional and post-transcriptional processes through its interaction with G-quadruplexes (G4s). The mechanisms by which DHX36 regulates G4s vary across different cell types and physiological conditions. Oocyte-specific conditional knockout (CKO) mice were utilized to study the impact of DHX36 deficiency on female fertility. The results show that the CKO mice exhibit severely impaired hormone response, ovulation, and complete infertility. The CKO germinal vesicle (GV) oocytes display large nucleoli, aberrant chromatin configuration, decreased chromatin accessibility, disturbed transcriptome, and inhibited meiosis progression. Following fertilization, the embryos derived from the CKO oocytes arrest at the zygote or 2-cell stage. Notably, we observed inadequate rRNA transcription in growing GV oocytes, as well as insufficient pre-rRNA processing and translation activity in fully-grown GV oocytes. Using a G4 probe and antibody, we found increased G4s formation at the chromatin and cytoplasm of CKO GV oocytes; these G4s mainly originate from the rDNA and pre-rRNA. Furthermore, the distribution of DHX36 was found to be spatiotemporally synchronized with that of pre-rRNA and G4s in early mouse embryos. In vitro experiments confirmed that DHX36 directly binds with pre-rRNA through the RHAU-specific motif (RSM). Overexpression of DHX36 could partially alleviate the pre-rRNA accumulation in fully-grown CKO oocytes. In conclusion, this study highlights the physiological significance of DHX36 in maintaining female fertility, underscoring its critical role in rRNA homeostasis and chromatin configuration through G4-unwinding mechanism in mouse oocytes. Show less
no PDF DOI: 10.1016/j.scib.2025.02.017
DHX36
Xuan Tie, Zhiang Chen, Shulei Yao +6 more · 2025 · Frontiers in bioscience (Landmark edition) · added 2026-04-24
Primary membranous nephropathy (pMN) often progresses to end-stage renal disease (ESRD) in the absence of immunosuppressive therapy. The immunological mechanisms driving pMN progression remain insuffi Show more
Primary membranous nephropathy (pMN) often progresses to end-stage renal disease (ESRD) in the absence of immunosuppressive therapy. The immunological mechanisms driving pMN progression remain insufficiently understood. We developed a single-cell transcriptomic profile of peripheral blood mononuclear cells (PBMCs) from 11 newly-diagnosed pMN patients and 5 healthy donors. Through correlation analysis, we identified potential biomarkers for disease stratification and poor prognosis. Expression levels of several proinflammatory factors were significantly increased in patients compared to healthy donors, such as interleukins ( Our study provides insight into the immunological mechanism of pMN and identifies numerous biomarkers and signaling pathways as potential therapeutic targets for managing the progression of high-risk pMN. Show less
no PDF DOI: 10.31083/FBL36332
DHX36
Wenna Liu, Shengchao Ma, Qingwei Lu +7 more · 2025 · Biology · MDPI · added 2026-04-24
Reproductive and growth traits are key economic traits in sheep. This study aims to identify key single nucleotide polymorphisms (SNPs) and candidate genes associated with reproductive and growth trai Show more
Reproductive and growth traits are key economic traits in sheep. This study aims to identify key single nucleotide polymorphisms (SNPs) and candidate genes associated with reproductive and growth traits in Tianmu polytocous sheep through a genome-wide association study (GWAS). The findings are expected to provide both a theoretical foundation for molecular breeding in this breed and novel insights into the genetic basis of ovine reproductive and growth performance. This study took 483 adult Tianmu polytocous ewes as the research subjects, collected their lambing records, measured their phenotypic values of growth traits (3 weight and 11 body size traits), and collected their blood samples for whole-genome resequencing to identify SNPs in the Tianmu polytocous sheep genome. The results identified a total of 9,499,019 (3× coverage) and 27,413,216 (30× coverage) high-quality SNPs in the Tianmu polytocous sheep genome. Subsequently, the association analysis between SNPs and reproductive and growth traits was conducted using a mixed linear model. A total of 92, 66, 18, 28, 6, 42, 3, 3, 6, 1, 12, 3, 22, 8, 6, and 3 SNPs were found associated with litter size at first parity, litter size at second parity, litter size at third parity, litter size at fourth parity, birth weight, weaning weight, body height, withers height, body length, head length, head width, cannon bone circumference, forelimb height, chest girth, chest depth, and withers width, respectively. Further, based on SNP annotation, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, candidate genes associated with the reproductive and growth traits were identified. Among these genes, 11 Show less
📄 PDF DOI: 10.3390/biology14101446
DLG2
L Zhang, Z Huang, M Luo +5 more · 2025 · British poultry science · Taylor & Francis · added 2026-04-24
1. Copy number variation (CNV) is an important source for identifying genetic differences. This study compared the genome-wide CNV and their regions (CNVR) across 16 Chinese local duck breeds and dete Show more
1. Copy number variation (CNV) is an important source for identifying genetic differences. This study compared the genome-wide CNV and their regions (CNVR) across 16 Chinese local duck breeds and detected key genes and pathways involved in growth and reproduction-related traits using this dataset.2. Breakdancer, Pindel and CNVnator were used to detect reliable CNV, and HandyCNV was used to obtain CNVR. Selection signatures were analysed in meat (MD) and egg-laying ducks (ED) compared to wild ducks (WD) using fixation and differentiation index DIsv methods. A Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was carried out to identify key pathways and related genes.3. Principal component analysis (PCA) using CNV data clustered 127 ducks into 4 populations: WD, MD, ED and meat+egg-type ducks (MED). In total, 237,630 CNV and 6,176 CNVR were detected across these samples. Intersection analysis identified 1,384 common CNVR and 2,105 unique CNVR. The KEGG analysis showed that common CNVR were enriched in 7 basic life activity pathways, while unique CNVR were enriched in 9 population-specific pathways. Compared to WD, MD selection signatures were found in 4 enriched pathways and 8 genes ( Show less
no PDF DOI: 10.1080/00071668.2025.2559392
DLG2
HanYu Zhu, Zhaoyang Wu, Junxiao Wang +8 more · 2025 · Schizophrenia research · Elsevier · added 2026-04-24
Schizophrenia (SZ) is a severe mental disorder with high heritability. DLG2 encodes the postsynaptic scaffolding protein DLG2 (PSD93, Postsynaptic Density Protein 93), and its variants were associated Show more
Schizophrenia (SZ) is a severe mental disorder with high heritability. DLG2 encodes the postsynaptic scaffolding protein DLG2 (PSD93, Postsynaptic Density Protein 93), and its variants were associated with an increased risk of SZ. However, the role of DLG2 locus variation in SZ remains elusive. This study aims to investigate the association between DLG2 gene polymorphisms and SZ susceptibility and the relationship between DLG2 and altered brain function and clinical symptoms in SZ patients. Single nucleotide polymorphisms (SNPs) rs11607886 and rs7479949 were genotyped in 350 SZ patients and 407 healthy controls (HCs). 47 SZ patients and 79 HCs were genotyped into two groups: the risk A allele carrier group and the GG-pure group. Functional magnetic resonance imaging (fMRI) indices were further analyzed. Subsequently, data from different brain regions were correlated with clinical symptom assessment. DLG2 rs11607886 was significantly associated with SZ. Significant main effects were found in the ALFF and ReHo, especially for the left precuneus gyrus (PCu). A significant interaction between genotype and diagnosis had a significant effect on FC, which was increased between the left PCu and the right middle temporal gyrus in carriers of the A allele with SZ (r = -0.336, P The rs11607886 polymorphism in DLG2 may influence the pathogenesis of SZ and have potential effects on cognitive function. The present study emphasizes DLG2 as a candidate gene for SZ and suggests an important role for PCu in SZ. Show less
no PDF DOI: 10.1016/j.schres.2025.04.004
DLG2
Bing-Hua Su, Chung-Teng Wang, Chia-Sing Lu +11 more · 2025 · Journal of Cancer · added 2026-04-24
The roles of cancer stem cells and Octamer-binding transcription factor 4 (OCT4) have been implicated in human tumorigenesis and metastasis. However, the role of OCT4 in the metastasis of non-small-ce Show more
The roles of cancer stem cells and Octamer-binding transcription factor 4 (OCT4) have been implicated in human tumorigenesis and metastasis. However, the role of OCT4 in the metastasis of non-small-cell lung cancer (NSCLC) remains undetermined, especially regarding stem cell-related pathways. Previous research has reported that dual-specificity phosphatase 6 (DUSP6), a mitogen-activated protein kinase (MAPK) phosphatase, is associated with cancer cells that display anti-apoptotic, migratory, and drug-resistance phenotypes. However, the regulation of DUSP6 in NSCLC is unclear. This study focused on the role of OCT4 in NSCLC, particularly its interaction with DUSP6. Here, we show a positive correlation between OCT4 and DUSP6 expression in NSCLC cells. Overexpression of OCT4 increased, whereas knockdown of OCT4 reduced DUSP6 expression. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays revealed that OCT4 transactivated DUSP6 expression by directly binding to the DUSP6 promoter, indicating that DUSP6 is a downstream target of OCT4. Furthermore, knockdown of DUSP6 in OCT4-overexpressing A549 human NSCLC cells decreased cell migration Show less
📄 PDF DOI: 10.7150/jca.108663
DUSP6